The Wegovy pill saw the fastest take-up in weight-loss drug history. Novo Nordisk only narrowly lifted guidance.
MarketWatch1 min readPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch